| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 47.869 | 112.735 | 197.690 | 176.916 | 235.637 | 263.774 | 269.412 | 247.742 |
| Total Income - EUR | - | - | 47.891 | 112.774 | 197.743 | 176.988 | 238.200 | 264.299 | 270.770 | 248.257 |
| Total Expenses - EUR | - | - | 39.875 | 103.653 | 174.558 | 168.675 | 215.016 | 231.601 | 240.506 | 209.983 |
| Gross Profit/Loss - EUR | - | - | 8.017 | 9.121 | 23.185 | 8.313 | 23.183 | 32.698 | 30.264 | 38.274 |
| Net Profit/Loss - EUR | - | - | 6.580 | 7.994 | 21.248 | 6.639 | 21.088 | 30.105 | 28.092 | 32.392 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Biotech Solutions S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 666 | 5.464 | 11.166 | 8.157 | 6.267 | 3.938 | 2.377 | 1.116 |
| Current Assets | - | - | 10.480 | 22.457 | 47.195 | 74.794 | 90.644 | 46.722 | 68.405 | 85.107 |
| Inventories | - | - | 523 | 686 | 847 | 10.671 | 10.089 | 3.429 | 2.175 | 5.330 |
| Receivables | - | - | 5.827 | 7.995 | 15.663 | 11.372 | 5.797 | 19.726 | 4.746 | 8.036 |
| Cash | - | - | 4.130 | 13.775 | 30.686 | 52.751 | 74.758 | 23.567 | 61.483 | 71.741 |
| Shareholders Funds | - | - | 6.624 | 11.271 | 28.381 | 17.853 | 38.545 | 30.153 | 41.703 | 73.862 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.522 | 16.649 | 29.981 | 65.099 | 58.367 | 20.507 | 29.079 | 12.361 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4690 - 4690" | |||||||||
| CAEN Financial Year |
4690
|
|||||||||
Comments - Biotech Solutions S.r.l.